We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NRXP market cap is 305.47M. The company's latest EPS is USD -0.3594 and P/E is -9.60.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.14M | -9.89M | -9.44M | -8.19M | -5.81M |
| Net Income | -9.08M | -10.24M | -11.04M | -8.72M | -6.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 10.16M | 771k | 0 | 0 |
| Operating Income | -713k | -51.39M | -115.8M | -44.34M | -27.84M |
| Net Income | 408k | -51M | -348.89M | -39.75M | -30.16M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 24.82M | 25.82M | 21.78M | 19.81M | 13.11M |
| Total Liabilities | 8.04M | 18.41M | 22.06M | 22.62M | 19.33M |
| Total Equity | 16.78M | 7.41M | -284k | -2.81M | -6.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 32.08M | 2.94M | 32.73M | 25.82M | 7.32M |
| Total Liabilities | 2.58M | 46.72M | 11.92M | 18.41M | 19.05M |
| Total Equity | 5M | -43.78M | 20.81M | 7.41M | -11.73M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -31.44M | -39.76M | -6.09M | -13.9M | -18.47M |
| Investing | -11k | -10k | -4k | -2k | -4k |
| Financing | 22.09M | 32.21M | 2.55M | 8.82M | 7.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -793k | -2.27M | -37.7M | -39.76M | -21.66M |
| Investing | 40.25M | -1,000 | -7k | -10k | -3k |
| Financing | -39.47M | 3.25M | 63.46M | 32.21M | 6.2M |
| Market Cap | 305.47M |
| Price to Earnings Ratio | -9.60 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 62.96 |
| Price to Book Ratio | -24.68 |
| Dividend Yield | - |
| Shares Outstanding | 83.92M |
| Average Volume (1 week) | 149.84k |
| Average Volume (1 Month) | 342.86k |
| 52 Week Change | -40.33% |
| 52 Week High | 12.00 |
| 52 Week Low | 2.21 |
| Spread (Intraday) | 0.09 (2.47%) |
| Company Name | NRX Pharmaceuticals Inc |
| Address |
1201 orange st wilmington, delaware 19801 |
| Website | https://www.nrxpharma.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
